• Promethera looks to Asia with €10m investment pharmaphorum
    January 03, 2019
    Belgium-based liver disease specialists Promethera Biosciences have received a leg-up for the Asian market in the form of a €10 million investment from Japanese business conglomerate ITOCHU Corporation.
PharmaSources Customer Service